National Health (Additional Community Supply Support Payment) Determination 2024

National Health (Additional Community Supply Support Payment) Determination 2024

PB 94 of 2024

made under paragraph 98B(1)(b) of the

National Health Act 1953

Compilation No. 4

Compilation date: 1 July 2026

Includes amendments: F2026L00770

About this compilation

This compilation

This is a compilation of the National Health (Additional Community Supply Support Payment) Determination 2024 that shows the text of the law as amended and in force on 1 July 2026 (the compilation date).

The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.

Uncommenced amendments

The effect of uncommenced amendments is not shown in the text of the compiled law. The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au).

Application, saving and transitional provisions

If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.

Editorial changes

For more information about any editorial changes made in this compilation, see the endnotes.

Presentational changes

The Legislation Act 2003 provides for First Parliamentary Counsel to make presentational changes to a compilation. Presentational changes are applied to give a more consistent look and feel to legislation published on the Register, and enable the user to more easily navigate those documents.

Modifications

If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. Any modifications affecting the law are accessible on the Register.

Self‑repealing provisions

If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.

Contents

1 Name

3 Authority

4 Definitions

5 ACSS eligible supplies

6 Amount of ACSS payment

Endnotes

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

1  Name

 (1) This instrument is the National Health (Additional Community Supply Support Payment) Determination 2024.

 (2) This instrument may also be cited as PB 94 of 2024.

3  Authority

  This instrument is made under paragraph 98B(1)(b) of the National Health Act 1953.

4  Definitions

 (1) In this instrument:

Act means the National Health Act 1953.

increased maximum quantity of a pharmaceutical benefit means the maximum quantity or number of units of the benefit or the pharmaceutical item in the benefit that may, in one prescription, be directed to be supplied on any one occasion, for a relevant purpose, under a determination of the Minister under paragraph 85A(2)(a) of the Act.

increased maximum quantity prescription means a prescription directing, for a relevant purpose, the supply on any one occasion of the increased maximum quantity of a pharmaceutical benefit.

relevant purpose, for a pharmaceutical benefit, means a purpose, mentioned in Schedule 4 to the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 for a purposes code (within the meaning of that instrument) specified in Schedule 1 to that instrument for the benefit, that includes the phrase “The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient”.

 (2) An expression that is used in this instrument and in Part VII of the Act has the same meaning in this instrument as it has in that Part.

Note: Examples of such expressions include the following:

(a) ACSS eligible supply;

(b) ACSS payment;

(c) approved pharmacist;

(d) pharmaceutical benefit;

(e) pharmaceutical item;

(f) Schedule equivalent.

5  ACSS eligible supplies

  For the purposes of subparagraph 98B(1)(b)(i) of the Act, a supply by an approved pharmacist of a pharmaceutical benefit is an ACSS eligible supply unless the supply is made in accordance with any of the following special arrangements under section 100 of the Act:

 (a) the National Health (Botulinum Toxin Program) Special Arrangement 2025;

 (b) the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024;

 (c) the National Health (Growth Hormone Program) Special Arrangement 2025;

 (d) the National Health (Highly Specialised Drugs Program) Special Arrangement 2021;

 (e) the National Health (IVF Program) Special Arrangement 2025;

 (f) the National Health (Take Home Naloxone) Special Arrangement 2019.

6  Amount of ACSS payment

 (1) For the purposes of subparagraph 98B(1)(b)(ii) of the Act, the amount of the ACSS payment for each ACSS eligible supply is:

 (a) if paragraph (b) of this subsection does not apply—$0.13; or

 (b) if subsection (2) or (3) of this section applies to the supply—the sum of:

 (i) the amount mentioned in paragraph (a) of this subsection; and

 (ii) $5.12.

Note: An approved pharmacist who wants to receive an ACSS payment must make a claim for the payment under section 99AAA of the Act. Entitlement to the payment is also subject to any applicable conditions determined under section 98C of the Act and the conditions set out in section 99AAAB of the Act.

 (2) This subsection applies to an ACSS eligible supply of a pharmaceutical benefit if:

 (a) the ACSS eligible supply is made upon an increased maximum quantity prescription directing the supply of:

 (i) the benefit; or

 (ii) another pharmaceutical benefit that is Schedule equivalent to the benefit; and

 (b) the ACSS eligible supply is of the increased maximum quantity of the benefit.

 (3) This subsection applies to an ACSS eligible supply of a pharmaceutical benefit if:

 (a) the ACSS eligible supply is made to a person in accordance with section 89A of the Act (which deals with supplies of pharmaceutical benefits without a prescription); and

 (b) the immediately preceding supply to the person of the benefit, or of another pharmaceutical benefit that is Schedule equivalent to the benefit, was made upon an increased maximum quantity prescription directing the supply of:

 (i) the benefit; or

 (ii) another pharmaceutical benefit that is Schedule equivalent to the benefit; and

 (c) both the ACSS eligible supply, and the immediately preceding supply referred to in paragraph (b) of this subsection, are of the increased maximum quantity of the relevant pharmaceutical benefit.

Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history

Abbreviation key—Endnote 2

The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4

Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.

Editorial changes

The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.

If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.

Misdescribed amendments

A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.

If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.

Endnote 2—Abbreviation key

Endnote 3—Legislation history

Endnote 4—Amendment history